Industry News

Industry News

Improved Outcomes In Lung Cancer Likely With Early Detection Techniques

Apr 19, 2012

New techniques for identifying lung cancer earlier - including a new type of chest screening, a nanotech 'nose' and a method to examine the cells of the cheek - are showing substantial promise, according to presentations at the 3rd European Lung Cancer Conference (ELCC) in Geneva. "Early detection of lung cancer is vital to improve lung cancer survival rates," commented Egbert F... Read More

Lung Cancer: Advances In Personalized Medicine

Apr 19, 2012

Several new studies that may help doctors tailor lung cancer treatment to the characteristics of individual patients and of their tumors were presented at the 3rd European Lung Cancer Conference in Geneva. "A major goal of lung cancer treatment is to tailor the treatment to the individual," says Dr Fiona Blackhall from The Christie NHS Foundation Trust in Manchester, UK... Read More

Oral Cancer Detection Could Dramatically Increase With Saliva Test

Apr 19, 2012

A Michigan State University surgeon is teaming up with a Lansing-area dental benefits firm on a clinical trial to create a simple, cost-effective saliva test to detect oral cancer, a breakthrough that would drastically improve screening and result in fewer people dying of the world's sixth most common cancer... Read More

Magnetic Nanochain Detonates Chemo Barrage Inside Breast Tumors

Apr 19, 2012

Medicine-toting nanochains slip into tumors and explode a chemotherapy drug into hard-to-reach cores of cancer, engineers and scientists at Case Western Reserve University report. In tests on rats and mice, the technology took out far more cancer cells, inhibited tumor growth better and extended life longer than traditional chemotherapy delivery... Read More

Researchers Identify A New Trigger For Alternate Reproduction Pathway Of HIV-Related Cancer Virus

Apr 19, 2012

A research team led by Children's National Medical Center has identified a trigger that causes latent Kaposi's sarcoma-associated herpesvirus (KSHV) to rapidly replicate itself. KSHV causes Kaposi's sarcoma, primary effusion lymphoma, and other cancers that commonly affect immunocompromised patients, including those with AIDS... Read More

Risk Of Relapse In Lung Cancer Patients Identified By Gene Signature

Apr 19, 2012

A new genetic signature identified by Spanish researchers may provide doctors with robust and objective information about which patients with early stage lung cancer are at low or high risk of relapse following surgery, investigators report at the 3rd European Lung Cancer Conference in Geneva. Their work also opens new avenues for immunotherapy for lung cancer... Read More

Use Of Erlotinib In Advanced Non-Small Cell Lung Cancer Guided By New Analysis

Apr 19, 2012

Patients with advanced non-small cell lung cancer should only receive treatment with the drug erlotinib before receiving standard chemotherapy if their tumor is known to harbor EGFR mutations, researchers report at the 3rd European Lung Cancer Conference in Geneva, Switzerland... Read More

Paving Way For Testing Therapy That Combines Brain Cancer Vaccine With The Drug Avastin

Apr 19, 2012

A new brain cancer vaccine tailored to individual patients by using material from their own tumors has proven effective in a multicenter phase 2 clinical trial at extending their lives by several months or longer. The patients suffered from recurrent glioblastoma multiforme - which kills thousands of Americans every year... Read More

Swallowing Exercises Help Head And Neck Cancer Patients, Short-Term

Apr 18, 2012

The April issue of Archives of Otolaryngology - Head & Neck Surgery reports that patients who undergo chemoradiation therapy (CRT), who perform specific swallowing exercises after their CRT, experience a short-term improvement in swallowing... Read More

Cancer Pain Frequently Undertreated, Especially Among Minorities

Apr 18, 2012

Researchers from The University of Texas MD Anderson Cancer Center have found that over 33.3% of individuals suffering from invasive cancer do not receive sufficient pain medication, with minorities twice as likely not to receive analgesics... Read More

Previous Page   Next Page